Romero’s risk ... no assessments done In one section of the CST, the assessment concluded Moscoso’s last use of alcohol was in 2019. That same section indicated his last use of drugs was ...

Plus, he added, the drugs may have a greater risk for adults who may have hypertension or underlying heart disease. Telehealth services have supercharged the trend, Levine warned — potentially ...

were associated with a significantly lower risk of Alzheimer's disease and related dementias (ADRD) compared to other diabetes drugs. Using data from over 90,000 patients, researchers reported ...

Popular diabetes and weight loss drugs may do more than curb appetites — they may also help reduce the risk of dementia, according to new research. Two studies that noted this unexpected effect ...

The study, published in Jama Neurology, found that another class of blood-sugar lowering diabetes drugs called SGLT2s also led to a significant reduction in dementia risk. Scientists said they ...

1:54 GLP-1 drugs like Ozempic, Wegovy reduce Alzheimer’s risk for those with diabetes Two major studies published Monday in JAMA Neurology found that GLP-1 medications are linked to a lower risk ...

FAT jabs may lower the risk of the UK's biggest killer, according to a study of almost 400,000 adults with type 2 diabetes. The research, published in JAMA Neurology, examined two types of drugs ...

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors, may be linked to a reduced risk of Alzheimer ... dementia using drugs already on the market.

Obesity and diabetes drugs, particularly semaglutides like Wegovy and Ozempic, may reduce a person’s risk of dementia, a new study suggests. Researchers found these medications show promise in ...

A common drug prescribed to help lower cholesterol levels has been found to cut dementia risk. High cholesterol has long been linked to general poor health, but a recent study published in the ...

Department of Foundational Medical Studies, William Beaumont School of Medicine, Oakland University, Rochester, Michigan 48309, United States *Address: William Beaumont School of Medicine, Oakland ...

(NewsNation) — An experimental drug has shown success in lowering the risk of genetically inherited heart disease by 94% during the second phase of its trial. Lepodisiran, an experimental drug from ...